Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods relating to DENND1A Variant 2 and polycystic ovary syndrome

Methods relating to DENND1A Variant 2 and polycystic ovary syndrome

US Patent 9957567 · Granted May 1, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods relating to DENND1A variant 2 and polycystic ovary synd2020
Compositions and methods relating to DENND1A variant 2 and polycystic ovary synd2020
Method for diagnosis of polycystic ovary syndrome (PCOS) by measuring levels of 2020
Method for diagnosis of polycystic ovary syndrome (PCOS) by measuring levels of 2020
Antibodies that recognize a DENN/MADD-domain-containing 1A variant 2 (DENND1A va2019
Antibodies that recognize a DENN/MADD-domain-containing 1A variant 2 (DENND1A va2019
Pharmaceutical compositions comprising DENND1A variant 2 and methods of use ther2017
Pharmaceutical compositions comprising DENND1A variant 2 and methods of use ther2017
Labor biomarkers, methods comprising same, and methods targeting same2012
Genetic markers for assessing risk of premature birth resulting from preterm pre2010
Labor biomarkers, methods comprising same, and methods targeting same2010
Methods and compositions for the treatment of defects in lipoprotein metabolism2007